NurExone Biologic: Funding, Investors & Team (Sep 2026)
NurExone Biologic is creating a drug platform using biological exosomes to repair damage in the Central Nerve System.
NurExone Biologic has raised $3.3M across 4 funding rounds on record, the most recent an undisclosed round of $560k announced in Aug 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NurExone Biologic Company Profile and Key Stats
Latest funding round on record: Aug 2025.
NurExone Biologic Funding Rounds
NurExone Biologic raised $250k in an undisclosed round announced in Oct 2023.
1.3 years later, an undisclosed round of $840k was announced in Jan 2025.
3 months later, an undisclosed round of $1.6M was announced in Apr 2025.
4 months later, an undisclosed round of $560k was announced in Aug 2025.
NurExone Biologic Founders and Leadership Team
Contact details for the NurExone Biologic team: 2 of 2 have an email address on file.
Start 14-day free trial →NurExone Biologic Funding Compared to Other Biotechnology Startups
NurExone Biologic's latest round of $560k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NurExone Biologic in Biotechnology and Haifa
Companies Similar to NurExone Biologic
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
NurExone Biologic Funding FAQs
What does NurExone Biologic do?
NurExone Biologic is creating a drug platform using biological exosomes to repair damage in the Central Nerve System.
How much funding has NurExone Biologic raised?
NurExone Biologic has raised $3.3M across 4 rounds on record. The most recent is an undisclosed round of $560k announced in Aug 2025.
When did NurExone Biologic last raise funding?
NurExone Biologic's most recent funding round on record is an undisclosed round of $560k, announced in Aug 2025.
Who founded NurExone Biologic?
FundedIQ lists Eran Ovadya (Founder), Lior Shaltiel (Founder) at NurExone Biologic.
Where is NurExone Biologic headquartered?
NurExone Biologic is based in Haifa, Hefa, Israel.
How many employees does NurExone Biologic have?
NurExone Biologic is in the 11-50 employee band.
How does NurExone Biologic's funding compare to other Biotechnology startups?
NurExone Biologic's latest round of $560k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's NurExone Biologic Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NurExone Biologic is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.